AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2016
Jun 28, 2016
30826_dirs_2016-06-28_dd541871-deca-4573-a7cb-726bd83aae57.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2016-06-27
Reporting Person: DAWES KAREN A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-06-27 | Common Stock | M | 15000 | $3.10 | Acquired | 57746 | Direct |
| 2016-06-27 | Common Stock | F | 1982 | $23.46 | Disposed | 55764 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-06-27 | Stock Option (Right to Buy) | $3.10 | M | 15000 | Disposed | 2016-09-15 | Common Stock (15000) | Direct |
Footnotes
F1: Payment made via forfeiture of 1,982 shares of Common Stock valued at the Closing Price of $23.46 on June 27, 2016.
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23